These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 34006847)

  • 1. Dynamics of neutralizing antibody responses to SARS-CoV-2 in patients with COVID-19: an observational study.
    Xu X; Nie S; Wang Y; Long Q; Zhu H; Zhang X; Sun J; Zeng Q; Zhao J; Liu L; Li L; Huang A; Hou J; Hou FF
    Signal Transduct Target Ther; 2021 May; 6(1):197. PubMed ID: 34006847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutralizing Antibodies in COVID-19 Patients and Vaccine Recipients after Two Doses of BNT162b2.
    Favresse J; Gillot C; Di Chiaro L; Eucher C; Elsen M; Van Eeckhoudt S; David C; Morimont L; Dogné JM; Douxfils J
    Viruses; 2021 Jul; 13(7):. PubMed ID: 34372570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Rapid and Efficient Screening System for Neutralizing Antibodies and Its Application for SARS-CoV-2.
    Han X; Wang Y; Li S; Hu C; Li T; Gu C; Wang K; Shen M; Wang J; Hu J; Wu R; Mu S; Gong F; Chen Q; Gao F; Huang J; Long Y; Luo F; Song S; Long S; Hao Y; Li L; Wu Y; Xu W; Cai X; Gao Q; Zhang G; He C; Deng K; Du L; Nai Y; Wang W; Xie Y; Qu D; Huang A; Tang N; Jin A
    Front Immunol; 2021; 12():653189. PubMed ID: 33828563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serological anti-SARS-CoV-2 neutralizing antibodies association to live virus neutralizing test titers in COVID-19 paucisymptomatic/symptomatic patients and vaccinated subjects.
    Cristiano A; Nuccetelli M; Pieri M; Sarubbi S; Pelagalli M; Calugi G; Tomassetti F; Bernardini S
    Int Immunopharmacol; 2021 Dec; 101(Pt B):108215. PubMed ID: 34649115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 neutralizing antibody levels are correlated with severity of COVID-19 pneumonia.
    Chen W; Zhang J; Qin X; Wang W; Xu M; Wang LF; Xu C; Tang S; Liu P; Zhang L; Liu X; Zhang Y; Yi C; Hu Z; Yi Y
    Biomed Pharmacother; 2020 Oct; 130():110629. PubMed ID: 33406577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early detection of neutralizing antibodies against SARS-CoV-2 in COVID-19 patients in Thailand.
    Putcharoen O; Wacharapluesadee S; Chia WN; Paitoonpong L; Tan CW; Suwanpimolkul G; Jantarabenjakul W; Ruchisrisarod C; Wanthong P; Sophonphan J; Chariyavilaskul P; Wang LF; Hemachudha T
    PLoS One; 2021; 16(2):e0246864. PubMed ID: 33577615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 neutralizing antibodies in patients with varying severity of acute COVID-19 illness.
    Jeewandara C; Jayathilaka D; Gomes L; Wijewickrama A; Narangoda E; Idampitiya D; Guruge D; Wijayamuni R; Manilgama S; Ogg GS; Tan CW; Wang LF; Malavige GN
    Sci Rep; 2021 Jan; 11(1):2062. PubMed ID: 33479465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 infection elicits a rapid neutralizing antibody response that correlates with disease severity.
    Trinité B; Tarrés-Freixas F; Rodon J; Pradenas E; Urrea V; Marfil S; Rodríguez de la Concepción ML; Ávila-Nieto C; Aguilar-Gurrieri C; Barajas A; Ortiz R; Paredes R; Mateu L; Valencia A; Guallar V; Ruiz L; Grau E; Massanella M; Puig J; Chamorro A; Izquierdo-Useros N; Segalés J; Clotet B; Carrillo J; Vergara-Alert J; Blanco J
    Sci Rep; 2021 Jan; 11(1):2608. PubMed ID: 33510275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can commercial automated immunoassays be utilized to predict neutralizing antibodies after SARS-CoV-2 infection? A comparative study between three different assays.
    Ismail A; Shurrab FM; Al-Jighefee HT; Al-Sadeq DW; Qotba H; Al-Shaar IA; Yassine HM; Abu-Raddad LJ; Nasrallah GK
    Front Biosci (Landmark Ed); 2021 Jul; 26(7):198-206. PubMed ID: 34340267
    [No Abstract]   [Full Text] [Related]  

  • 10. Persisting Neutralizing Activity to SARS-CoV-2 over Months in Sera of COVID-19 Patients.
    Flehmig B; Schindler M; Ruetalo N; Businger R; Bayer M; Haage A; Kirchner T; Klingel K; Normann A; Pridzun L; Tougianidou D; Ranke MB
    Viruses; 2020 Nov; 12(12):. PubMed ID: 33260809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of SARS-CoV-2 Neutralizing Antibodies to an Automated Chemiluminescent Serological Immunoassay.
    Grenache DG; Ye C; Bradfute SB
    J Appl Lab Med; 2021 Mar; 6(2):491-495. PubMed ID: 33098417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of Anti-SARS-CoV-2 Antibodies in Recovered COVID-19 Subjects.
    Huynh A; Arnold DM; Smith JW; Moore JC; Zhang A; Chagla Z; Harvey BJ; Stacey HD; Ang JC; Clare R; Ivetic N; Chetty VT; Bowdish DME; Miller MS; Kelton JG; Nazy I
    Viruses; 2021 Apr; 13(4):. PubMed ID: 33923828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delayed neutralizing antibody response in the acute phase correlates with severe progression of COVID-19.
    Kawasuji H; Morinaga Y; Tani H; Kimura M; Yamada H; Yoshida Y; Takegoshi Y; Kaneda M; Murai Y; Kimoto K; Ueno A; Miyajima Y; Kawago K; Fukui Y; Sakamaki I; Yamamoto Y
    Sci Rep; 2021 Aug; 11(1):16535. PubMed ID: 34400739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody (IgA, IgG, and IgG Subtype) Responses to SARS-CoV-2 in Severe and Nonsevere COVID-19 Patients.
    Patil HP; Rane PS; Shrivastava S; Palkar S; Lalwani S; Mishra AC; Arankalle VA
    Viral Immunol; 2021 Apr; 34(3):201-209. PubMed ID: 33656935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asymptomatic and Mild SARS-CoV-2 Infections Elicit Lower Immune Activation and Higher Specific Neutralizing Antibodies in Children Than in Adults.
    Petrara MR; Bonfante F; Costenaro P; Cantarutti A; Carmona F; Ruffoni E; Di Chiara C; Zanchetta M; Barzon L; Donà D; Da Dalt L; Bortolami A; Pagliari M; Plebani M; Rossi P; Cotugno N; Palma P; Giaquinto C; De Rossi A
    Front Immunol; 2021; 12():741796. PubMed ID: 34659235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans.
    Seow J; Graham C; Merrick B; Acors S; Pickering S; Steel KJA; Hemmings O; O'Byrne A; Kouphou N; Galao RP; Betancor G; Wilson HD; Signell AW; Winstone H; Kerridge C; Huettner I; Jimenez-Guardeño JM; Lista MJ; Temperton N; Snell LB; Bisnauthsing K; Moore A; Green A; Martinez L; Stokes B; Honey J; Izquierdo-Barras A; Arbane G; Patel A; Tan MKI; O'Connell L; O'Hara G; MacMahon E; Douthwaite S; Nebbia G; Batra R; Martinez-Nunez R; Shankar-Hari M; Edgeworth JD; Neil SJD; Malim MH; Doores KJ
    Nat Microbiol; 2020 Dec; 5(12):1598-1607. PubMed ID: 33106674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetic Characteristics of Neutralizing Antibody Responses Vary among Patients with COVID-19.
    Li LH; Tu HW; Liang D; Wen CY; Li AA; Lin WY; Hu KQ; Hong WS; Li YP; Su J; Zhao ST; Li W; Yuan RY; Zhou PP; Hu FY; Tang XP; Ke CW; Ke BX; Cai WP
    Biomed Environ Sci; 2021 Dec; 34(12):976-983. PubMed ID: 34981720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early and High SARS-CoV-2 Neutralizing Antibodies Are Associated with Severity in COVID-19 Patients from India.
    Shrivastava S; Palkar S; Shah J; Rane P; Lalwani S; Mishra AC; Arankalle VA
    Am J Trop Med Hyg; 2021 Jun; 105(2):401-406. PubMed ID: 34138748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutralizing antibody responses over time in demographically and clinically diverse individuals recovered from SARS-CoV-2 infection in the United States and Peru: A cohort study.
    Karuna S; Li SS; Grant S; Walsh SR; Frank I; Casapia M; Trahey M; Hyrien O; Fisher L; Miner MD; Randhawa AK; Polakowski L; Kublin JG; Corey L; Montefiori D;
    PLoS Med; 2021 Dec; 18(12):e1003868. PubMed ID: 34871308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Robust neutralizing antibodies to SARS-CoV-2 infection persist for months.
    Wajnberg A; Amanat F; Firpo A; Altman DR; Bailey MJ; Mansour M; McMahon M; Meade P; Mendu DR; Muellers K; Stadlbauer D; Stone K; Strohmeier S; Simon V; Aberg J; Reich DL; Krammer F; Cordon-Cardo C
    Science; 2020 Dec; 370(6521):1227-1230. PubMed ID: 33115920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.